Missed the First Wave of Artificial Intelligence (AI) Stocks? These 2 Aggressive Plays Are Your Second-Chance Buys

CoreWeave and Nebius are positioned to capture the next wave of AI cloud (“neocloud”) demand, but both are funding aggressive data-center buildouts via debt and share issuance while remaining unprofitable. Nebius reported Q1 revenue up 684% YoY, with projections of +547% growth in 2026 and +233% in 2027; CoreWeave’s Q1 revenue rose 112% YoY to $2.1B and backlog is near $100B, with analyst growth expectations of +147% in 2026 and +98% in 2027. The key risk flagged is rising leverage and potential shareholder dilution alongside execution risk—making these higher-beta AI plays versus earlier “winners.”

Analysis

The key market takeaway is that these names are not just AI growth stories; they are financing stories. In the near term, the winners are the asset-light enablers — NVDA, AVGO, TSM, and the hyperscalers MSFT/META — because they monetize the capex cycle without bearing much balance-sheet risk, while the neoclouds absorb depreciation, lease, and refinancing risk. That usually means the equity upside is capped by a rising cost of capital even when revenue growth stays exceptional.

The second-order risk is that backlog can look like demand durability while really being a funding constraint test. Over 1-3 months, the stocks can keep trading on contract announcements and AI momentum; over 2-4 quarters, the real variables are utilization, gross margin per deployed GPU, and access to debt/convert markets. If credit spreads widen or hyperscaler capex pauses, CRWV/NBIS can reprice much faster than the underlying demand narrative changes.

Contrarian view: the market may be overestimating the permanence of outsourced AI compute. If MSFT/META decide they can internalize more capacity or demand better pricing, the neoclouds’ backlog quality falls even if headline revenue stays strong. Best expression is to own the picks-and-shovels with durable balance sheets and fade the levered capacity providers; if the AI buildout keeps accelerating, NVDA/AVGO participate, but CRWV/NBIS remain vulnerable to dilution and a multiple reset.

Key Decisions for Investors

• Prefer long NVDA/AVGO over CRWV/NBIS on any AI-capex strength: same demand vector, materially lower balance-sheet risk, better risk/reward over 6-18 months.
• Use rallies in CRWV and NBIS to initiate a small short or put-spread hedge; thesis fails if they show durable positive free cash flow or materially lower net leverage over the next 2-3 quarters.
• Pair trade idea: long MSFT or META vs short CRWV/NBIS to express hyperscaler demand growth without financing risk; best entered after any post-news squeeze.
• Watch high-yield spreads and convertible market access for CRWV/NBIS as the nearest catalyst; widening spreads would likely pressure both names within days to weeks.